JASCAYD (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China
The approval marks the first new treatment option for people living with…
Igyxos Biotherapeutics Announces Positive Results from Phase 1 Trial of IGX12, its First-in-Class Monoclonal Antibody for the Treatment of Male and Female Infertility
December 10, 2025 04:00 ET | Source: Igyxos TOURS, France, Dec. 10,…
Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion
WAYNE, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a…
Xcell Biosciences and Culture Biosciences Partner to Advance Cell Therapy Quality Through AI and Machine Learning
SAN FRANCISCO, CALIFORNIA, UNITED STATES, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Xcell…
Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University
- First patient in the world treated with Alpha DaRT® in the…
Digital Culture Group Dominates Awards Season With Wins in AI Innovation
Adweek Tech Stack Awards Recognize DCG’s ARI-Driven Success with Edmond’s Honor Bourbon…
TransAlta Signs Long-Term Agreement for 700 MW at Centralia Facility Enabling Coal to Natural Gas Conversion
December 09, 2025 07:00 ET | Source: TransAlta Corporation CALGARY, Alberta, Dec.…
Aeluma Files New Patent That Enhances Intellectual Property for Large-Scale High Performance Semiconductor Manufacturing
Strengthens Aeluma’s Heterogeneous Integration Platform and Expands Intellectual Property Portfolio to 35…
Zelluna ASA – Mandatory notification of trade
Reference is made to the private placement (the "Private Placement") and the retail…
Ipsen – November 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares composing…
